1. Randomized Clinical Trial: Perioperative Rifaximin Is Not Associated with Enhanced Functional and Volumetric Recovery after Major Liver Resection (ARROW). (2022) Authors: Bednarsch, J.; Czigany, Z.; Loosen, S.H.; Heij, L.R.; Ruckgaber, L.; Maes, H.; Krause, J.-P.; Reen, M.; Toteva, B.; Vosdellen, T.; Bruners, P.; Lang, S.A.; Ulmer, T.F.; Roderburg, C.; Luedde, T.; Neumann, U.P. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗